Munafa Stock Market Course + Intraday & FNO calls 
Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Protagonist Therapeutics (PTGX)
Technical Analysis Report for NASDAQ stock PTGX Protagonist Therapeutics. Dated: 11 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock PTGX Protagonist Therapeutics then click here. or read Experts views on Protagonist Therapeutics or Forecast & share price targets of Protagonist Therapeutics
Protagonist Therapeutics Opened at 96.84 and Closed at: 96.48, which is -0.59% of previous session's close. It moved within a range of 95.97 and 98.32
The session was a Bearish session with an average volume of 788700, which is -8.53% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- Even though the stock has fallen, but its mid term trend is positive and in an uptrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
Support for tomorrow is 95.05 and resistance for tomorrow is 97.4
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 95.53, 94.57 resistance for tomorrow's hourly charts is 97.88, 99.27
10 Day SMA for Protagonist Therapeutics (PTGX) is 93.45 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Protagonist Therapeutics (PTGX) is 88.59 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Protagonist Therapeutics (PTGX) is 85.36 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 84.82 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Protagonist Therapeutics is 71.2 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Protagonist Therapeutics is at 88.59 and 200 DMA is at 71.2, while 50 DMA and 100 DMA are at 85.36 and 84.82 respectively
Protagonist Therapeutics (PTGX) moving average of 20 SMA is at 88.59 and 20 EMA is at 90.33
| Date | Closing Price | 20 SMA | 20 EMA |
| 11 Wed Mar | 96.48 | 88.59 | 90.33 |
| 10 Tue Mar | 97.05 | 87.94 | 89.68 |
| 09 Mon Mar | 96.66 | 87.28 | 88.91 |
| 06 Fri Mar | 92.09 | 86.62 | 88.1 |
| 05 Thu Mar | 91.41 | 86.24 | 87.68 |
| 04 Wed Mar | 94.83 | 85.7 | 87.29 |
Protagonist Therapeutics (PTGX) moving average of 50 SMA is at 85.36 and 50 EMA is at 86.85
| Date | Closing Price | 50 SMA | 50 EMA |
| 11 Wed Mar | 96.48 | 85.36 | 86.85 |
| 10 Tue Mar | 97.05 | 85.19 | 86.46 |
| 09 Mon Mar | 96.66 | 85.02 | 86.03 |
| 06 Fri Mar | 92.09 | 84.87 | 85.6 |
| 05 Thu Mar | 91.41 | 84.8 | 85.34 |
| 04 Wed Mar | 94.83 | 84.72 | 85.09 |
Protagonist Therapeutics (PTGX) moving average of 100 SMA is at 84.82 and 100 EMA is at 82.41
| Date | Closing Price | 100 SMA | 100 EMA |
| 11 Wed Mar | 96.48 | 84.82 | 82.41 |
| 10 Tue Mar | 97.05 | 84.61 | 82.13 |
| 09 Mon Mar | 96.66 | 84.42 | 81.83 |
| 06 Fri Mar | 92.09 | 84.22 | 81.53 |
| 05 Thu Mar | 91.41 | 84.09 | 81.32 |
| 04 Wed Mar | 94.83 | 84.05 | 81.12 |
Protagonist Therapeutics (PTGX) moving average of 200 SMA is at 71.2 and 200 EMA is at 73.76
| Date | Closing Price | 200 SMA | 200 EMA |
| 11 Wed Mar | 96.48 | 71.2 | 73.76 |
| 10 Tue Mar | 97.05 | 70.95 | 73.53 |
| 09 Mon Mar | 96.66 | 70.69 | 73.29 |
| 06 Fri Mar | 92.09 | 70.44 | 73.05 |
| 05 Thu Mar | 91.41 | 70.21 | 72.86 |
| 04 Wed Mar | 94.83 | 69.98 | 72.67 |
Protagonist Therapeutics has performed better than Vericel Corporation in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than China Sxt in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Neuronetics Inc in short term. Holding Protagonist Therapeutics could be a better choice for now!
Sol Gel has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Sol Gel, about 6.11% more returns!
Solid Biosciences has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Solid Biosciences, about 9.05% more returns!
Protagonist Therapeutics has performed better than Myriad Genetics in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Innoviva Inc in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Eton Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Ensign Group in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Denali Therapeutics in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Citius Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Cellectis S in short term. Holding Protagonist Therapeutics could be a better choice for now!
Celldex Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Celldex Therapeutics, about 14.74% more returns!
Protagonist Therapeutics has performed better than Aquestive Therapeutics in short term. Holding Protagonist Therapeutics could be a better choice for now!
Anika Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Anika Therapeutics, about 24.98% more returns!
Protagonist Therapeutics has performed better than Agenus Inc in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics has performed better than Ac Immune in short term. Holding Protagonist Therapeutics could be a better choice for now!
Acadia Healthcare has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Acadia Healthcare, about 32.59% more returns!
Protagonist Therapeutics Technical analysis of indicators
Price action analysis of Protagonist Therapeutics (PTGX) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Protagonist Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Protagonist Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Protagonist Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a buy signal for Protagonist Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Protagonist Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 93.65 and Protagonist Therapeutics PTGX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Protagonist Therapeutics PTGX stock. Volume based technical analysis of Protagonist Therapeutics PTGX stock is negative.
Protagonist Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock PTGX Protagonist Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And PTGX Experts View which covers a lot of information including buying and selling signals
PTGX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Protagonist Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
